Breastcancer-genetics
2021 – 2030 of 2270
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
(
- Contribution to journal › Article
-
Mark
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk
(
- Contribution to journal › Article
-
Mark
Abnormal nuclear shape in solid tumors reflects mitotic instability
(
- Contribution to journal › Article
-
Mark
Antitumor effect of radioactive cisplatin (191Pt) on nude mice
(
- Contribution to journal › Article
-
Mark
Expression of the B-cell transcription factor PU.1 is strongly correlated with CD10, CD79a, CD20, CD22, and bcl-6 expression in diffuse large B-cell lymphoma (DLBCL)
(
- Contribution to journal › Article
-
Mark
Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
(
- Contribution to journal › Article
-
Mark
Voluntary associations for cancer patients in Sweden: supportive activities
(
- Contribution to journal › Article
-
Mark
DNA and cell cycle analysis as prognostic indicators in breast tumors revisited
(
- Contribution to journal › Article